Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

1D to 3D Crossover of a Spin-Imbalanced Fermi Gas.

Revelle MC, Fry JA, Olsen BA, Hulet RG.

Phys Rev Lett. 2016 Dec 2;117(23):235301. Epub 2016 Nov 30.

PMID:
27982646
2.

Development of reference values for the Functional Mobility Assessment.

Marchese VG, Oriel KN, Fry JA, Kovacs JL, Weaver RL, Reilly MM, Ginsberg JP.

Pediatr Phys Ther. 2012 Fall;24(3):224-30. doi: 10.1097/PEP.0b013e31825c87e7.

PMID:
22735469
3.

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.

Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ; Rizatriptan Protocol 082 Pediatric Migraine Study Group.

Cephalalgia. 2012 Jul;32(10):750-65. Epub 2012 Jun 18.

PMID:
22711898
4.

A survey study to characterize use of Spice products (synthetic cannabinoids).

Vandrey R, Dunn KE, Fry JA, Girling ER.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):238-41. doi: 10.1016/j.drugalcdep.2011.07.011. Epub 2011 Aug 10.

5.

Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2.

Pettit GR, Quistorf PD, Fry JA, Herald DL, Hamel E, Chapuis JC.

J Nat Prod. 2009 May 22;72(5):876-83. doi: 10.1021/np800635h.

6.

Optimization of platelet therapy.

Fry JA, Grines CL.

Semin Interv Cardiol. 2000 Sep;5(3):117-28. Review.

PMID:
11054909
7.

Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.

Chorich LJ, Derick RJ, Chambers RB, Cahill KV, Quartetti EJ, Fry JA, Bush CA.

Ophthalmology. 1998 Mar;105(3):428-31.

PMID:
9499772
8.

Intracranial findings in progressive facial hemiatrophy.

Fry JA, Alvarellos A, Fink CW, Blaw ME, Roach ES.

J Rheumatol. 1992 Jun;19(6):956-8.

PMID:
1404134

Supplemental Content

Loading ...
Support Center